Abstract
Interferons are cytokines secreted in response to viral infections with potent antiviral activity, and they represent a critical component of the innate immune response against viruses. It has now become apparent that many viruses have evolved different mechanisms to counteract the interferon response, allowing their efficient replication and propagation in their hosts. This review discusses how the development of reverse genetics techniques and the increase in our knowledge of the interferon response have led to the discovery of interferon-antagonistic functions of different genes of viruses belonging to the negative-strand RNA virus group. In many cases, these viral genes encode accessory proteins that are not required for viral infectivity but are critical for optimal replication and for virulence in the host.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akira S, Hemmi H (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85: 85–95
Andrejeva J, Poole E, Young DF, Goodbourn S, Randall RE (2002) The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5. J. Virol. 76: 11379–11386
Andrejeva J, Young DF, Goodbourn S, Randall RE (2002) Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J. Virol. 76: 2159–2167
Aragón T, de La Luna S, Novoa I, Carrasco L, Ortín J, Nieto A (2000) Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol. Cell. Biol. 20: 6259–6268
Atreya PL, Kulkarni S (1999) Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA. Virology 261: 227–241
Baron MD, Barrett T (2000) Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J. Virol. 74: 2603–2611
Basler CF, Wang X, Mühlberger E, Volchkov V, Paragas J, Klenk H-D, García-Sastre A, Palese P (2000) The Ebola virus VP35 protein functions as a type I interferon antagonist. Proc. Natl. Acad. Sci. ( USA ) 97: 12289–12294
Basler CF, Reid AH, Dybing JK, Janczewski TA, Fanning TG, Zheng H, Salvatore M, Perdue ML, Swayne DE, García-Sastre A, Palese P, Taubenberger JK (2001) Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc. Natl. Acad. Sci. ( USA ) 98: 2746–2751
Bergmann M, García-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T (2000) Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74: 6203–6206
Bergmann M, Romirer I, Sachet M, Fleischhacker R, García-Sastre A, Palese P, Wolff K, Pehamberger H, Jakesz R, Muster T (2001) A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res. 61: 8188–8193
Biron CA, Sen GC (2001) Interferons and other cytokines. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds) Fields Virology. Lippincott-Raven, Philadelphia, pp 321–351
Black BL, Lyles DS (1992) Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J. Virol. 66: 4058–4064
Bossert B, Conzelmann KK (2002) Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J. Virol. 76: 4287–4293
Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, Haller O (2001) Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J. Virol. 75: 1371–1377.
Bucher E, Sijen T, De Haan P, Goldbach R, Prins M (2003) Negative-strand tospoviruses and tenuiviruses carry a gene for a suppressor of gene silencing at analogous genomic positions. J. Virol. 77: 1329–1336
Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5: 919–923
Chatziandreou N, Young D, Andrejeva J, Goodbourn S, Randall RE (2002) Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistence. Virology 293: 234–242
Chen Z, Li Y, Krug RM (1999) Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3’-end processing machinery. EMBO J. 18: 2273–2283
Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360: 1831–1837
Coffey MC, Strong JE, Forsyth PA, Lee PW (1998) Reovirus therapy of tumors with activated Ras pathway. Science 282: 1332–1334
Curran J, Boeck R, Kolakofsky D (1991) The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J. 10: 3079–3085
Delenda C, Hausmann S, Garcin D, Kolakofsky D (1997) Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology 228: 55–62
Der SD, Zhou A, Williams BR, Silverman RH (1998) Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. ( USA ) 95: 15623–15628
Didcock L, Young DF, Goodbourn S, Randall RE (1999) The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J.Virol. 73: 9928–9933
Didcock L, Young DF, Goodbourn S, Randall RE (1999) Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J. Virol. 73: 3125–3133
Durbin AP, McAuliffe JM, Collins PL, Murphy BR (1999) Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. Virology 261: 319–330
Egorov A, Brandt S, Sereinig S, Romanova J, Ferko B, Katinger D, Grassauer A, Alexandrova G, Katinger H, Muster T (1998) Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J. Virol. 72: 6437–6441
Enninga J, Levy DE, Blobel G, Fontoura BM (2002) Role of nucleoporin induction in releasing an mRNA nuclear export block. Science 295: 1523–1525
Escoffier C, Manie S, Vincent S, Muller CP, Billeter M, Gerlier D (1999) Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J. Virol. 73: 1695–1698
Ferran MC, Lucas-Lenard JM (1997) The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J. Virol. 71: 371–377
Francoeur AM, Poliquin L, Stanners CP (1987) The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis. Virology 160: 236–245
Gale MJ, Katze MG (1998) Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78: 29–46
Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252: 324–330
Garcin D, Latorre P, Kolakofsky D (1999) Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J. Virol. 73: 6559–6565
Garcin D, Curran J, Kolakofsky D (2000) Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. J. Virol. 74: 8823–8830
Garcin D, Curran J, Itoh M, Kolakofsky D (2001) Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J. Virol. 75: 6800–6807
Garcin D, Marq JB, Strahle L, le Mercier P, Kolakofsky D (2002) All four Sendai Virus C proteins bind Statl, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 295: 256–265
Garcin D, Marq JB, Goodbourn S, Kolakofsky D (2003) The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Statl and bulk Statl levels independently of interferon signaling. J. Virol. 77: 2321–2329
Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER (2002) Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. ( USA ) 99: 13837–13842
Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, Garcia-Sastre A (2002) Cellular transcriptional profiling in influenza A virus infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. ( USA ) 99: 10736–10741
Gotoh B, Takeuchi K, Komatsu T, Yokoo J, Kimura Y, Kurotani A, Kato A, Nagai Y (1999) Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-a/ß-mediated responses. FEBS Lett. 459: 205–210
Gotoh B, Takeuchi K, Komatsu T, Yokoo J (2003) The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol 77: 3360–70
Grote D, Russell SJ, Cornu TI, Cattaneo R, Vile R, Poland GA, Fielding AK (2001) Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 97: 3746–3754
Gupta M, Mahanty S, Ahmed R, Rollin PE (2001) Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-lalpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. Virology 284: 20–25
Hagmaier K, Jennings S, Buse J, Weber F, Kochs G (2003) Novel gene product of thogotovirus segment 6 codes for an interferon antagonist. J. Virol. 77: 2747–2752
Haller O, Kochs G (2002) Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3: 710–717
Harcourt BH, Sanchez A, Offermann MK (1998) Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells. Virology 252: 179–188
Harcourt BH, Sanchez A, Offermann MK (1999) Ebola virus selectively inhibits responses to interferons, but not to interleukin-lbeta, in endothelial cells. J. Virol. 73: 3491–3496
Hatada E, Fukuda R (1992) Binding of influenza A virus NS1 protein to dsRNA in vitro. J. Gen. Virol. 73: 3325–3329
Hatada E, Saito S, Fukuda R (1999) Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J. Virol. 73: 2425 2433
Hatta M, Gao P, Halfmann P, Kawaoka Y (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza Aviruses. Science 293: 1840–1842
He B, Paterson RG, Stock N, Durbin JE, Durbin RK, Goodbourn S, Randall RE, Lamb RA (2002) Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 303: 15–32
Her LS, Lund E, Dahlberg JE (1997) Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276: 1845–1848
Hermodsson S (1963) Inhibition of interferon by an infection with parainfluenza virus type 3 (PIV-3). Virology 29: 333–343
Isaacs A, Lindenmann J (1957) Virus interference. 1. The interferon. Proc. R. Soc. Lond. B. 147: 258–267
Isaacs A, Burke DC (1958) Mode of action of interferon. Nature 4642: 1073–1076
Kato A, Kiyotani K, Sakai Y, Yoshida T, Nagai Y (1997) The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16: 578–587
Kato A, Kiyotani K, Sakai Y, Yoshida T, Shioda T, Nagai Y (1997) Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J. Virol. 71: 7266–7272
Kato A, Ohnishi Y, Kohase M, Saito S, Tashiro M, Nagai Y (2001) Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J. Virol. 75: 3802–3810
Kato A, Ohnishi Y, Hishiyama M, Kohase M, Saito S, Tashiro M, Nagai Y (2002) The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesis. J. Virol. 76: 7114–7124
Katz JM, Lu X, Tumpey TM, Smith CB, Shaw MW, Subbarao K (2000) Molecular cor-relates of influenza A H5N1 virus pathogenesis in mice. J. Virol. 74: 10807–10810
Katze MG, He Y, Gale M, Jr. (2002) Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2: 675–687
Kawano M, Kaito M, Kozuka Y, Komada H, Noda N, Nanba K, Tsurudome M, Ito M, Nishio M, Ito Y (2001) Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain. Virology 284: 99–112
Kim MJ, Latham AG, Krug RM (2002) Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc. Natl. Acad. Sci. ( USA ) 99: 10096–10101
Komatsu T, Takeuchi K, Yokoo J, Tanaka Y, Gotoh B (2000) Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription. J. Virol. 74: 2477–2480
Komatsu T, Takeuchi K, Yokoo J, Gotoh B (2002) Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Statl. FEBS Lett. 511: 139–144
Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP (2003) IFN-2s mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4: 69–77
Kubota T, Yokosawa N, Yokota S, Fujii N (2001) C terminal Cys-rich region of mumps virus structural V protein correlates with block of interferon a and y signal transduction pathway through decrease of STAT 1-a. Biochem. Biophys. Res. Commun. 283: 255–259
Kubota T, Yokosawa N, Yokota S, Fujii N (2002) Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex. J. Virol. 76: 12676–12682
Kurotani A, Kiyotani K, Kato A, Shioda T, Sakai Y, Mizumoto K, Yoshida T, Nagai Y (1998) Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells 3: 111–124
Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1: 398–401
Lamb RA, Kolakofsky D (2001) Paramyxoviridae: The viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds) Fields Virology. Lippincott-Raven, Philadelphia, pp 1305–1340
Lee TG, Tomita J, Hovanessian AG, Katze MG (1990) Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc. Natl. Acad. Sci. ( USA ) 87: 62086212
Lee TG, Tomita J, Hovanessian AG, Katze MG (1992) Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. J. Biol. Chem. 267: 14238–14243
Levy DE, García-Sastre A (2001) The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 12: 143–156.
Lin GY, Paterson RG, Richardson CD, Lamb RA (1998) The V protein of the para-myxovirus SV5 interacts with damage-specific DNA binding protein. Virology 249: 189–200
Lu Y, Wambach M, Katze MG, Krug RM (1995) Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214: 222–228
Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, Planz O, Pleschka S, GarcíaSastre A, Heins G, Wolff T (2002) The influenza A virus NSI protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J. Virol. 76: 11166–11171
Marcus PI, Rodriguez LL, Sekellick MJ (1998) Interferon induction as a quasispecies marker of vesicular stomatitis virus populations. J. Virol. 72: 542–549
Mebatsion T, Verstegen S, De Vaan LT, Romer-Oberdorfer A, Schrier CC (2001) A recombinant Newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J. Virol. 75: 420–428
Mrkic B, Odermatt B, Klein MA, Billeter MA, Pavlovic J, Cattaneo R (2000) Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J. Virol. 74: 1364–1372
Naniche D, Yeh A, Eto D, Manchester M, Friedman RM, Oldstone MB (2000) Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of alpha/beta interferon production. J. Virol. 74: 7478–7484
Nemeroff ME, Qian XY, Krug RM (1995) The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology 212: 422–428
Nishio M, Tsurudome M, Ito M, Kawano M, Komada H, Ito Y (2001) High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons. J. Virol. 75: 9165–9176
Nishio M, Garcin D, Simonet V, Kolakofsky D (2002) The carboxyl segment of the mumps virus V protein associates with STAT proteins in vitro via a tryptophanrich motif. Virology 300: 92–99
Noah DL, Twu KY, Krug RM (2203) Cellular antiviral processes against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3’ end processing of cellular premRNAs. Virology 307: 386–395
Norton GP, Tanaka T, Tobita K, Nakada S, Buonaugurio DA, Greenspan D, Krystal M, Palese P (1987) Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology 156: 204–213
Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T (2003) TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4: 161–167
Overton HA, Ihara T, Bishop DH (1987) Identification of the N and NSs proteins coded by the ambisense S RNA of Punta Toro phlebovirus using monospecific antisera raised to baculovirus expressed N and NSs proteins. Virology 157: 338–350
Palese P, Basler CF, Garcia-Sastre A (2002) The makings of a killer. Nat. Med. 8: 927928
Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks GD, Lamb RA, Horvath CM (2001) The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283: 230–239
Parisien JP, Lau JF, Horvath CM (2002) STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J. Virol. 76: 6435–6441
Parisien JP, Lau JF, Rodriguez JJ, Ulane CM, Horvath CM (2002) Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J. Virol. 76: 41904198
Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, GarcíaSastre A, Basler CF (2003) Newcastle disease virus ( NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 77: 1501–1511
Patel RC, Sen GC (1998) PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17: 4379–4390
Patterson JB, Thomas D, Lewicki H, Billeter MA, Oldstone MB (2000) V and C pro- teins of measles virus function as virulence factors in vivo. Virology 267: 80–89
Peng KW, Ahmann GJ, Pham L, Greipp PR, Cattaneo R, Russell SJ (2001) Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood 98: 2002–2007
Poole E, He B, Lamb RA, Randall RE, Goodbourn S (2002) The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology 303: 33–46
Qian XY, Chien CY, Lu Y, Montelione GT, Krug RM (1995) An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA 1: 948–956
Rodriguez JJ, Parisien JP, Horvath CM (2002) Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76: 11476–11483
Saito S, Ogino T, Miyajima N, Kato A, Kohase M (2002) Dephosphorylation failure of tyrosine-phosphorylated STAT1 in IFN-stimulated Sendai virus C protein-expressing cells. Virology 293: 205–209
Salvatore M, Basler CF, Parisien J-P, Horvath CM, Bourmakina S, Zheng H, Muster T, Palese P, Garcia-Sastre A (2002) Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J. Virol. 76: 1206–1212
Samuel CE (2001) Antiviral actions of interferons. Clin. Microbiol. Rev. 14: 778–809
Schirrmacher V, Haas C, Bonifer R, Ahlert T, Gerhards R, Ertel C (1999) Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus. Gene Ther. 6: 63–73
Schlender J, Bossert B, Buchholz U, Conzelmann KK (2000) Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/ beta interferon-induced antiviral response. J. Virol. 74: 8234–8242
Schneider H, Kaelin K, Billeter MA (1997) Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology 227: 314–322
Sekellick MJ, Carra SA, Bowman A, Hopkins DA, Marcus PI (2000) Transient resistance of influenza virus to interferon action attributed to random multiple packaging and activity of NS genes. J. Interferon Cytokine Res. 20: 963–970
Sen GC, Ransohoff RM (1993) Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42: 57–102
Seo SH, Hoffmann E, Webster RG (2002) Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8: 950–954
Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4: 63–68
Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835–1837
Smith EJ, Marié I, Prakash A, García-Sastre A, Levy DE (2001) IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or IKB kinase but is blocked by vaccinia virus E3L protein. J. Biol. Chem. 276: 8951–8957
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu. Rev. Biochem. 67: 227–264
Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N, Bell JC (2000) Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6: 821–825
Takeda A, Sugiyama K, Nagano H, Mori M, Kaido M, Mise K, Tsuda S, Okuno T (2002) Identification of a novel RNA silencing suppressor, NSs protein of Tomato spotted wilt virus. FEBS Lett. 532: 75–79
Takeuchi K, Komatsu T, Yokoo J, Kato A, Shioda T, Nagai Y, Gotoh B (2001) Sendai virus C protein physically associates with Statl. Genes Cells 6: 545–557
Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, García-Sastre A (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74: 7989–7996
Talon J, Salvatore M, O’Neill RE, Nakaya Y, Zheng H, Muster T, García-Sastre A, Palese P (2000) Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc. Natl. Acad. Sci. ( USA ) 97: 4309–4314
Tan SL, Katze MG (1998) Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J. Interferon Cytokine Res. 18: 757–766
tenOever BR, Servant MJ, Grandvaux N, Lin R, Hiscott J (2002) Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J. Virol. 76: 3659–3669
Tober C, Seufert M, Schneider H, Billeter MA, Johnston IC, Niewiesk S, ter Meulen V, Schneider-Schaulies S (1998) Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J. Virol. 72: 8124–8132
Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S, Williams BR, Major J, Hamilton TA, Fenton MJ, Vogel SN (2002) TLR4, but not TLR2, mediates IFN-beta-induced STATlalpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3: 392–398
Tumpey TM, García-Sastre A, Mikulasova A, Taubenberger JK, Swayne DE, Palese P, Basler CF (2002) Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. ( USA ) 99: 13849–13854
Ulane CM, Horvath CM (2002) Paramyxoviruses SV5 and hPIV2 assemble STAT pro- tein ubiquitin ligase complexes from cellular components. Virology 304: 160–166
Usacheva A, Smith R, Minshall R, Baida G, Seng S, Croze E, Colamonici 0 (2001) The WD motif-containing protein receptor for activated protein kinase C (RACK1) is required for recruitment and activation of signal transducer and activator of transcription 1 through the type I interferon receptor. J. Biol. Chem. 276: 22948–22953
Valsamakis A, Schneider H, Auwaerter PG, Kaneshima H, Billeter MA, Griffin DE (1998) Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72: 7754–7761
von Kobbe C, van Deursen JM, Rodrigues JP, Sitterlin D, Bachi A, Wu X, Wilm M, Carmo-Fonseca M, Izaurralde E (2000) Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol. Cell 6: 1243–1252
Wang W, Krug RM (1996) The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology 223: 41–50
Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A (2000) Influenza A virus NS1 protein prevents the activation of NF-xB and induction of type I IFN. J. Virol. 74: 11566–11573
Wang X, Basler CF, Williams BRG, Silverman RH, Palese P, Garcia-Sastre A (2002) Functional replacement of the carboxy-terminal two thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J. Virol. 76: 12951–12962
Wansley EK, Parks GD (2002) Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death. J. Virol. 76: 10109–10121
Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1: 507–518
Weber F, Bridgen A, Fazakerley JK, Streitenfeld H, Kessler N, Randall RE, Elliott RM (2002) Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J. Virol. 76: 7949–7955
Williams BR (1999) PKR; a sentinel kinase for cellular stress. Oncogene 18: 6112–6120
Yokosawa N, Kubota T, Fujii N (1998) Poor induction of interferon-induced 2’,5’oligoadenylate synthetase (2–5 AS) in cells persistently infected with mumps virus is caused by decrease of STAT-la. Arch. Virol. 143: 1985–1992
Yokosawa N, Yokota S, Kubota T, Fujii N (2002) C-terminal region of STAT-la is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J Virol 76: 12683–12690
Young DF, Didcock L, Goodbourn S, Randall RE (2000) Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269: 383–390
Young DF, Chatziandreou N, He B, Goodbourn S, Lamb RA, Randall RE (2001) Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J. Virol. 75: 3363–3370
Young DF, Andrejeva L, Livingstone A, Goodbourn S, Lamb RA, Collins PL, Elliott RM, Randall RE (2003) Virus replication in engineered human cells that do not respond to interferons. J. Virol. 77: 2174–2181
Yuan W, Krug RM (2001) Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20: 362–371
Yuan W, Aramini JM, Montelione GT, Krug RM (2002) Structural basis for ubiquitin-like ISG 15 protein binding to the NS1 protein of influenza B virus: a protein-protein interaction function that is not shared by the corresponding N-terminal domain of the NS1 protein of influenza A virus. Virology 304: 291–301
Zeng J, Fournier P, Schirrmacher V (2002a) Stimulation of human natural interferon-alpha response via paramyxovirus hemagglutinin lectin-cell interaction. J. Mol. Med. 80: 443–451
Zeng J, Fournier P, Schirrmacher V (2002b) Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus. Virology 297: 19–30
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
García-Sastre, A. (2004). Identification and Characterization of Viral Antagonists of Type I Interferon in Negative-Strand RNA Viruses. In: Kawaoka, Y. (eds) Biology of Negative Strand RNA Viruses: The Power of Reverse Genetics. Current Topics in Microbiology and Immunology, vol 283. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06099-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-06099-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07375-5
Online ISBN: 978-3-662-06099-5
eBook Packages: Springer Book Archive